Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-09

Clinical Trial Update: Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of bimatoprost ophthalmic solution to increase eyelash prominence in eyelash hypotrichosis; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost ophthalmic solution (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Eyelash Hypotrichosis | Phase 2 | Status: COMPLETED | Results posted: 2011-12-09